Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis rehabilitation.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
[Anti-neurofascin antibody in combined central and peripheral demyelination].
Systematic imaging review: Multiple Sclerosis.
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.
Cannabinoids and autoimmune diseases: A systematic review.
A New Method to Segment the Multiple Sclerosis Lesions on Brain Magnetic Resonance Images.
Schwann cells-axon interaction in myelination.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Randomized controlled pilot study of customized pamphlets to promote physical activity and symptom self-management in women with multiple sclerosis.
Vitamin d: shining a light on clinical and sex specific effects in multiple sclerosis?
Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelization attacks.
Pages
« first
‹ previous
…
666
667
668
669
670
671
672
673
674
…
next ›
last »